BNC Korea Co Ltd
KOSDAQ:256840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BNC Korea Co Ltd
KOSDAQ:256840
|
KR |
|
Qualisys Holding AB (publ)
F:R0A
|
SE |
|
Alembic Ltd
NSE:ALEMBICLTD
|
IN |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
Matas A/S
CSE:MATAS
|
DK |
|
Kourakuen Holdings Corp
TSE:7554
|
JP |
|
China Yuchai International Ltd
NYSE:CYD
|
SG |
BNC Korea Co Ltd
BNC Korea Co., Ltd. researches and develops strategic application products which include medical devices, pharmaceuticals, and cosmetic products containing physiologically active substances by processing hyaluronic acid and collagen. The company is headquartered in Daegu, Daegu. The company went IPO on 2016-12-28. The firm's main products include hyaluronic acid (HA) fillers, collagen wound dressings, antiadhesion materials and collagen tissue supplements, and others. In addition, the Company produces and sells cosmetics, medicines and medical devices, among others.
BNC Korea Co., Ltd. researches and develops strategic application products which include medical devices, pharmaceuticals, and cosmetic products containing physiologically active substances by processing hyaluronic acid and collagen. The company is headquartered in Daegu, Daegu. The company went IPO on 2016-12-28. The firm's main products include hyaluronic acid (HA) fillers, collagen wound dressings, antiadhesion materials and collagen tissue supplements, and others. In addition, the Company produces and sells cosmetics, medicines and medical devices, among others.
